ORPGAN DRUGS
September 1st, 2002
BY KEITH NUTHALL
THE FIRST update to the European Union's inventory of national policies and regulations promoting the availability of orphan drugs has been completed and published by the European Commission. This new detailed inventory lists all incentives made available by the EU and its Member States to support research into orphan medicinal products.
*Full copy: http://pharmacos.eudra.org/F2/orphanmp/doc/updinventory_0802.pdf
THE FIRST update to the European Union's inventory of national policies and regulations promoting the availability of orphan drugs has been completed and published by the European Commission. This new detailed inventory lists all incentives made available by the EU and its Member States to support research into orphan medicinal products.
*Full copy: http://pharmacos.eudra.org/F2/orphanmp/doc/updinventory_0802.pdf
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.